Closed system transfer devices (CSTD) are used to transfer medication from one system to another, with the aim of limiting the potential for drug contamination and hazardous drug exposure. Oncology professionals significantly use closed system transfer devices so as to protect themselves from aerosols, vapors, and droplets of harmful chemotherapy drugs.
Closed system transfer devices market was valued at USD 785.9 million in 2018 and is expected to reach USD 2,988.5 million in 2026, growing at a CAGR of 18.0%
Closed System Transfer Devices Market Segmentation |
|
| By Closing Mechanism | 1. Luer-Lock System |
| 2. Push-To-Turn System | |
| By Product Type | 1. Needleless System |
| 2. Membrane-To-Membrane System | |
| By Technology | 1. Air Filtration Devices |
| 2. Diaphragm Devices | |
| 3. Compartmentalized Devices | |
| By Region | 1. North America (US and Canada) |
| 2. Europe (UK, Germany, France and Rest of Europe) | |
| 3. Asia Pacific (China, Japan, India and Rest of Asia Pacific) | |
| 4. Latin America (Brazil, Mexico and Rest of Latin America) | |
| 5. Middle East & Africa (GCC and Rest of Middle East & Africa) | |
The major factors driving the growth of the market include the rising prevalence of cancer along with the rising number of oncology drug approvals across the globe. The implementation of government regulations regarding the safety of healthcare facilities in developed economies of North America and Europe is another factor that is significantly propelling market growth. However, the high costs of closed system transfer devices coupled with its lack of awareness in underdeveloped economies are certain factors hindering the global market growth. The increasing application of closed system transfer devices in other therapeutic areas along with its increasing adoption in emerging economies due to rising healthcare infrastructure is anticipated to offer growth opportunity to the global closed system transfer devices market in the near future.
The push-to-turn closed system transfer devices segment contributes a major share in the global market
Based on the closing mechanism, the global closed system transfer devices market has been segmented into luer-lock system and push-to-turn system. Among these mechanisms, the push-to-turn closed system transfer devices segment registers a remarkable share in the market. The major factor that drives its growth is its enhanced safety features.
The membrane-to-membrane closed system transfer devices segment expected to grow at the fastest rate, a CAGR of 25%, during the forecast period
Based on the type of products, the market has been segmented into a needleless system and membrane-to-membrane system. Among these products, the membrane-to-membrane closed system transfer devices has projected the fastest growth in the global market during the forecast period. This is due to its certain beneficial properties, such as its barrier properties, which substantially reduces the possibilities of the contamination of the drugs. It provides an added layer of protection between the medication vial and the syringe, which offers an enhanced safety from contamination, as compared to needleless membranes. These advantageous features of membrane-to-membrane system are expected to propel its demand in the closed system transfer devices market in the near future.
The diaphragm-based closed system transfer devices estimated to hold a major share in the global market
Based on the technology, the market has been segmented into air filtration devices, diaphragm devices, and compartmentalized devices. The diaphragm-based closed system transfer devices segment accounted to project considerable growth in the market in 2018 and account for almost 48% market share, owing to its ease of operation and safety offered by this closing mechanism.
North America to dominate the global closed system transfer devices market throughout the forecast period
North America accounted for nearly 40% share of the global closed system transfer devices market in 2018 and is expected to dominate the market throughout the forecast period, followed by Europe. The region is regarded as the prominent adopter of advanced technologies for its well-developed healthcare infrastructure, owing to which, there is a significant demand for closed system transfer devices in the region. Moreover, the high prevalence of cancer and presence of key market players in the US, such as Becton, Dickinson and Company and Equashield LLC, are some other major factors propelling the market growth in the region.
Company Profiles and Competitive Intelligence:
The major players operating in the global closed system transfer devices market are Becton, Dickinson, and Company (US), B. Braun Medical Inc. (Germany), ICU Medical, Inc. (US), Equashield LLC (US), Baxter International, Inc. (US), Caragen Ltd. (Ireland), Corvida Medical (US), JMS Co. Ltd. (US), Victus, Inc. (US), and Yukon Medical LLC (US), among others.
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
TABLE OF CONTENT
Chapter 1 Executive Summary
1.1. Market Summary
1.1.1. Global Closed System Transfer Devices Market, 2016-2026, (USD Million)
1.2. Market Snapshot: Global Closed System Transfer Devices Market
1.3. Market Dynamics
1.4. Global Closed System Transfer Devices Market, by Segment, 2018
1.4.1. Global Closed System Transfer Devices Market, by Closing Mechanism, 2018, (USD Million)
1.4.2. Global Closed System Transfer Devices Market, by Product Type, 2018, (USD Million)
1.4.3. Global Closed System Transfer Devices Market, by Technology, 2018, (USD Million)
1.4.4. Global Closed System Transfer Devices Market, by Region, 2018 (USD Million)
1.5. Premium Insights
1.5.1. Closed System Transfer Devices Market In Developed Vs. Developing Economies, 2018 vs 2026
1.5.2. Global Closed System Transfer Devices Market: Regional Life Cycle Analysis
Chapter 2 Market Dynamics
2.1. Market Overview
2.2. Market Drivers
2.2.1. Increasing prevalence of cancer
2.2.2. Improving regulatory guidelines
2.2.3. Rising number of oncology drug approvals
2.3. Market Restraints
2.3.1. Lack of awareness regarding the benefits of CSTD
2.3.2. High cost of CSTD
2.4. Market Opportunities
2.4.1. Increasing application of CSTD in untapped therapeutic areas
2.4.2. Substantial opportunity of CSTD in emerging market
2.5. Industry Value Chain Analysis
2.6. Pricing Analysis
2.7. Porter’s Five Forces Analysis
Chapter 3 Global Closed System Transfer Devices Market, by Closing Mechanism
3.1. Market Overview, by Closing Mechanism
3.1.1. Global Closed System Transfer Devices Market, by Closing Mechanism, 2016-2026 (USD Million)
3.1.2. Incremental Opportunity, by Closing Mechanism, 2018
3.2. Luer-Lock System
3.2.1. Global Closed System Transfer Devices Market, by Luer-Lock System, 2016-2026, (USD Million)
3.3. Push-To-Turn System
3.3.1. Global Closed System Transfer Devices Market, by Push-To-Turn System, 2016-2026, (USD Million)
Chapter 4 Global Closed System Transfer Devices Market, by Product Type
4.1. Market Overview, by Product Type
4.1.1. Global Closed System Transfer Devices Market, by Product Type, 2016-2026 (USD Million)
4.1.2. Incremental Opportunity, by Product Type, 2018
4.2. Needleless System
4.2.1. Global Closed System Transfer Devices Market, by Needleless System, 2016-2026, (USD Million)
4.3. Membrane-To-Membrane System
4.3.1. Global Closed System Transfer Devices Market, by Membrane-To-Membrane System, 2016-2026, (USD Million)
Chapter 5 Global Closed System Transfer Devices Market, by Technology
5.1. Market Overview, by Technology
5.1.1. Global Closed System Transfer Devices Market, by Technology, 2016-2026 (USD Million)
5.1.2. Incremental Opportunity, by Technology, 2018
5.2. Air Filtration Devices
5.2.1. Global Closed System Transfer Devices Market, by Air Filtration Devices, 2016-2026, (USD Million)
5.3. Diaphragm Devices
5.3.1. Global Closed System Transfer Devices Market, by Diaphragm Devices, 2016-2026, (USD Million)
5.4. Compartmentalized Devices
5.4.1. Global Closed System Transfer Devices Market, by Compartmentalized Devices, 2016-2026, (USD Million)
Chapter 6 Global Closed System Transfer Devices Market, by Region
6.1. Market Overview, by Region
6.1.1. Global Closed System Transfer Devices Market, by Region, 2016-2026, (USD Million)
6.2. Attractive Investment Opportunity, by Region, 2018
6.3. North America Closed System Transfer Devices Market
6.3.1. North America Closed System Transfer Devices Market, by Closing Mechanism, 2016-2026 (USD Million)
6.3.2. North America Closed System Transfer Devices Market, by Product Type, 2016-2026 (USD Million)
6.3.3. North America Closed System Transfer Devices Market, by Technology, 2016-2026 (USD Million)
6.3.4. United States Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.3.5. Canada Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.4. Europe Closed System Transfer Devices Market
6.4.1. Europe Closed System Transfer Devices Market, by Closing Mechanism, 2016-2026 (USD Million)
6.4.2. Europe Closed System Transfer Devices Market, by Product Type, 2016-2026 (USD Million)
6.4.3. Europe Closed System Transfer Devices Market, by Technology, 2016-2026 (USD Million)
6.4.4. United Kingdom Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.4.5. Germany Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.4.6. France Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.4.7. Rest of Europe Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.5. Asia Pacific Closed System Transfer Devices Market
6.5.1. Asia Pacific Closed System Transfer Devices Market, by Closing Mechanism, 2016-2026 (USD Million)
6.5.2. Asia Pacific Closed System Transfer Devices Market, by Product Type, 2016-2026 (USD Million)
6.5.3. Asia Pacific Closed System Transfer Devices Market, by Technology, 2016-2026 (USD Million)
6.5.4. China Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.5.5. Japan Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.5.6. India Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.5.7. Rest of Asia Pacific Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.6. Latin America Closed System Transfer Devices Market
6.6.1. Latin America Closed System Transfer Devices Market, by Closing Mechanism, 2016-2026 (USD Million)
6.6.2. Latin America Closed System Transfer Devices Market, by Product Type, 2016-2026 (USD Million)
6.6.3. Latin America Closed System Transfer Devices Market, by Technology, 2016-2026 (USD Million)
6.6.4. Brazil Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.6.5. Mexico Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.6.6. Rest of Latin America Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.7. Middle East & Africa Closed System Transfer Devices Market
6.7.1. Middle East & Africa Closed System Transfer Devices Market, by Closing Mechanism, 2016-2026 (USD Million)
6.7.2. Middle East & Africa Closed System Transfer Devices Market, by Product Type, 2016-2026 (USD Million)
6.7.3. Middle East & Africa Closed System Transfer Devices Market, by Technology, 2016-2026 (USD Million)
6.7.4. GCC Closed System Transfer Devices Market, 2016-2026 (USD Million)
6.7.5. Rest of Middle East & Africa Closed System Transfer Devices Market, 2016-2026 (USD Million)
Chapter 7 Competitive Intelligence
7.1. Top 5 Players Comparison
7.2. Market Positioning of Key Players, 2018
7.3. Market Players Mapping
7.3.1. By Type
7.3.2. By Phase
7.3.3. By Application
7.3.4. By Region
7.4. Strategies Adopted by Key Market Players
7.5. Recent Developments in the Market
7.5.1. Mergers & Acquisitions, Partnership, New Product Developments
Chapter 8 Company Profiles
8.1. Becton, Dickinson and Company
8.1.1. Becton, Dickinson and Company Overview
8.1.2. Becton, Dickinson and Company Products Portfolio
8.1.3. Becton, Dickinson and Company Financial Overview
8.1.4. Becton, Dickinson and Company News/Recent Developments
8.2. B. Braun Medical Inc.
8.2.1. B. Braun Medical Inc. Overview
8.2.2. B. Braun Medical Inc. Products Portfolio
8.2.3. B. Braun Medical Inc. Financial Overview
8.2.4. B. Braun Medical Inc. News/Recent Developments
8.3. ICU Medical, Inc.
8.3.1. ICU Medical, Inc. Overview
8.3.2. ICU Medical, Inc. Products Portfolio
8.3.3. ICU Medical, Inc. Financial Overview
8.3.4. ICU Medical, Inc. News/Recent Developments
8.4. Equashield LLC
8.4.1. Equashield LLC Overview
8.4.2. Equashield LLC Products Portfolio
8.4.3. Equashield LLC Financial Overview
8.4.4. Equashield LLC News/Recent Developments
8.5. Baxter International, Inc.
8.5.1. Baxter International, Inc. Overview
8.5.2. Baxter International, Inc. Products Portfolio
8.5.3. Baxter International, Inc. Financial Overview
8.5.4. Baxter International, Inc. News/Recent Developments
8.6. Caragen Ltd.
8.6.1. Caragen Ltd. Overview
8.6.2. Caragen Ltd. Products Portfolio
8.6.3. Caragen Ltd. Financial Overview
8.6.4. Caragen Ltd. News/Recent Developments
8.7. Corvida Medical
8.7.1. Corvida Medical Overview
8.7.2. Corvida Medical Products Portfolio
8.7.3. Corvida Medical Financial Overview
8.7.4. Corvida Medical News/Recent Developments
8.8. JMS Co. Ltd.
8.8.1. JMS Co. Ltd. Overview
8.8.2. JMS Co. Ltd. Products Portfolio
8.8.3. JMS Co. Ltd. Financial Overview
8.8.4. JMS Co. Ltd. News/Recent Developments
8.9. Victus, Inc.
8.9.1. Victus, Inc. Overview
8.9.2. Victus, Inc. Products Portfolio
8.9.3. Victus, Inc. Financial Overview
8.9.4. Victus, Inc. News/Recent Developments
8.10. Yukon Medical LLC
8.10.1. Yukon Medical LLC Overview
8.10.2. Yukon Medical LLC Products Portfolio
8.10.3. Yukon Medical LLC Financial Overview
8.10.4. Yukon Medical LLC News/Recent Developments
Chapter 9 Preface
9.1. Data Triangulation
9.2. Research Methodology
9.2.1. Phase I – Secondary Research
9.2.2. Phase II – Primary Research
9.2.3. Phase III – Expert Panel Review
9.2.4. Approach Adopted
9.2.4.1. Top-Down Approach
9.2.4.2. Bottom-Up Approach
9.2.5. Supply- Demand side
9.2.6. Breakup of the Primary Profiles
Log in / Register
